// App-Quantinova.ai

T5063 2016 AHA : Three-Year Clinical Outcome of Patients Treated With the Nobori Biolimus-Eluting Stent and Xience/Promus Cobalt-Chromium Everolimus-Eluting Stent for Unprotected Left Main Disease

Researchers

Presenter

  • Shoichi Kuramitsu

Principal Investigators

  • Hiroyuki Jinnouchi

  • Takashi Morinaga

  • Yohei Kobayashi

  • Takenori Domei

  • Makoto Hyodo

  • Yoshimitsu Soga

  • Shinichi Shirai

  • Kenji Ando

Medical Centers

  • Kokura memorial hospital, Kitakyusyu, Japan

Locations

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Myocardial infarction

  • Left main disease

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • Everolimus

  • Crofelemer

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved